Pharma Plays With Fire
Generic competition has helped put the brakes on pharmaceutical manufacturers' growth in recent years. Branded drugmakers compensated for generic competition through consolidation, which provided firms with fuller pipelines and thus more time to make up for patent expirations. Still, generics continued to eat away at sales as pharma companies' R&D productivity remained stalled.